Non-Small Cell Lung Cancer

When you come to us for diagnosis or treatment for non-small cell lung cancer, you can typically see each member of our group on the same day. Your team may include pulmonologists, thoracic surgeons, medical oncologists, radiation oncologists, and interventional radiologists. This multidisciplinary team of internationally renowned experts creates a treatment plan that’s customized for you.

We use a variety of tests on tissue and blood to learn as much about the lung cancer as possible, helping us create the best treatment plan for you.

Our clinical trials can provide the newest therapeutic options, such as targeted drugs and immunotherapy. We also offer many supportive services, such as lung rehabilitation, psychological care, and integrative health therapies.

Clinical Trials and Research Studies

Phase 1

Phase 1/1b Study to Evaluate the Safety & PK of JNJ-73841937 a Third Generation EGFR-TKI as Monotherapy or in Combinations With JNJ-61186372 a Human Bispecific EGFR and cMet Antibody in Participants With Advanced NSCLC

Learn More

Phase 2

A Phase II study of Concurrent Chemoradiation plus Durvalumab (MEDI4736) followed by Surgery followed by Adjuvant Durvalumab (MEDI4736) in medically operable patients with surgically resectable Stage III (N2) Non-Small Cell Lung Cancer: A Hoosier Cancer Research Network Clinical Trial LUN 17-321

Learn More

Phase 1

A Phase 1 Study of RGX-104 a Small Molecule LXR Agonist as a Single Agent and as Combination Therapy in Patients with Advanced Solid Malignancies and Lymphoma with an Expansion in Select Malignancies

Learn More

Phase 2

A Phase 2 Open-Label Single-Arm Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor

Learn More